Search research articles
Contact Us
Filters
Showing results (91-100 of 193) with videos related to
Page
of 20
Sort By:
Virchows Archiv : an International Journal of Pathology
|
April 8, 2021
Incidental lymphomas in surgical pathology: diagnostic clues and clinical-pathological correlations
Marco Pizzi, Marta Sbaraglia, Alberto Bellan, et al.
Blood Advances
|
August 5, 2022
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort
Gianluigi Reda, Veronica Mattiello, Anna Maria Frustaci, et al.
American Journal of Hematology
|
October 31, 2025
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib-A Case Report and a Review of the Literature
Giovanni Leone, Mattia D'Antiga, Michela Pelloso, et al.
Oncogene
|
January 13, 2018
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes
Laura Patrussi, Nagaja Capitani, Francesca Cattaneo, et al.
Frontiers in Cell and Developmental Biology
|
February 23, 2024
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation
Ludovica Lopresti, Nagaja Capitani, Vanessa Tatangelo, et al.
Frontiers in Oncology
|
September 20, 2024
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
Alessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, et al.
Cancers
|
March 28, 2024
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course
Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, et al.
Histopathology
|
December 20, 2024
CD23 expression in lymphoplasmacytic lymphoma: Clinical-pathological and biological correlations
Marco Pizzi, Nicolò Danesin, Federico Scarmozzino, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 3, 2019
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments
Andrea Visentin, Monica Facco, Carmela Gurrieri, et al.
Oncotargets and Therapy
|
October 16, 2020
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia
Andrea Visentin, Federica Frezzato, Filippo Severin, et al.
Page
of 20
Search research articles
Search
Showing results (91-100 of 193) with videos related to
Sort By:
Page
of 20
Virchows Archiv : an International Journal of Pathology
|
April 8, 2021
Incidental lymphomas in surgical pathology: diagnostic clues and clinical-pathological correlations
Marco Pizzi, Marta Sbaraglia, Alberto Bellan, et al.
Blood Advances
|
August 5, 2022
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort
Gianluigi Reda, Veronica Mattiello, Anna Maria Frustaci, et al.
American Journal of Hematology
|
October 31, 2025
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib-A Case Report and a Review of the Literature
Giovanni Leone, Mattia D'Antiga, Michela Pelloso, et al.
Oncogene
|
January 13, 2018
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes
Laura Patrussi, Nagaja Capitani, Francesca Cattaneo, et al.
Frontiers in Cell and Developmental Biology
|
February 23, 2024
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation
Ludovica Lopresti, Nagaja Capitani, Vanessa Tatangelo, et al.
Frontiers in Oncology
|
September 20, 2024
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
Alessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, et al.
Cancers
|
March 28, 2024
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course
Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, et al.
Histopathology
|
December 20, 2024
CD23 expression in lymphoplasmacytic lymphoma: Clinical-pathological and biological correlations
Marco Pizzi, Nicolò Danesin, Federico Scarmozzino, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 3, 2019
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments
Andrea Visentin, Monica Facco, Carmela Gurrieri, et al.
Oncotargets and Therapy
|
October 16, 2020
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia
Andrea Visentin, Federica Frezzato, Filippo Severin, et al.
Page
of 20